You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Prostate cancer

Prostate cancer Products

A list of all our products on prostate cancer

Filter

Product type

PathwaysGuidanceQuality standardsAdviceShared learning

Advice programme
1 selected

Evidence summariesMedtech innovation briefings

Status

PublishedIn development

Showing 2 products

Date | Sort by Title

Advice programme: Evidence summariesRemove ‘Advice programme: Evidence summaries’ filter

Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)
Product type:
Advice
Programme:
Evidence summary
Published date:
5 January 2016
Prostate cancer: triptorelin (Decapeptyl SR) (ESNM30)
Product type:
Advice
Programme:
Evidence summary
Published date:
13 January 2014

About NICE
Into practice
News
Contact us
Leave feedback
Jobs

Newsletters and alerts
Blog
Twitter
YouTube
Facebook
LinkedIn

Explore

Guidance
Pathways
Standards and indicators
Evidence search
BNF
BNFC
Clinical knowledge summaries
Journals and databases

Reusing our content

Reuse information
NICE UK Open Content Licence

Get involved

Register as a stakeholder
Citizens council
Consultations
Fellows and scholars
Join a committee
Meetings in public
Student champions
Tenders
NICE and the public

Accessibility
Freedom of information
Syndication services
Glossary
Terms and conditions
Privacy notice

© NICE [year]. All rights reserved. Subject to Notice of rights.